NanoTemper Technologies unveils Dianthus uHTS — the fastest biophysical method on the market
Three things we took away from attending Drug Discovery Chemistry in 2024
8 Targeted Protein Degradation conferences in 2023 you won’t want to miss
9 Targeted Protein Degradation conferences you don’t want to miss in 2022
10 terms to help you more easily understand targeted protein degradation
NanoTemper Technologies launches Spectral Shift, a breakthrough technology that changes the game for affinity-based screenings
For protein degraders to tackle neurodegenerative diseases, these are the barriers they need to overcome
Why so many companies are betting on PROTACs as a superior therapeutic modality
Protein degraders show promising results in drug development pipelines. See progress candidates have made.
